Lung Cancer
Cheryl Bellomo, MSN, RN, HON-ONN-CG, OCN, Deborah Christensen, RN, BSN, HNB-BC, Tricia Strusowski, RN, MS
February 2016 Vol 7, No 1 | February 1, 2016
The authors present a case demonstrating the critical role of nurse navigators in community outreach and ultimately early detection and education for patients.
December 2015 Vol 6, No 6 | January 4, 2016
The multidisciplinary care model is perceived to be
more patient-centered and efficient for patients
with lung cancer than the serial care model, according
to Satish K. Kedia, PhD, Professor, Division of
Social and Behavioral Sciences, School of Public Health,
University of Memphis, TN, and colleagues.
Caroline Kornhauser, MPH, Sarah Quinlan, Nian Hu, Christian Washington, Dawn Zador, Carolyn Messner, DSW, OSW-C, LCSW-R
February 2015, Vol 6, No 1 | March 20, 2015
This article describes the stigma that may be associated with a lung cancer diagnosis and its impact on body image, self-perception, and coping. Also explored are ways in which this stigma may be alleviated by the multidisciplinary oncology team, with particular emphasis on the important role oncology nurses play in the care of these patients.
February 2015, Vol 6, No 1 | March 20, 2015
“There’s a lot we don’t know about lung cancer screening,” according to Denise Aberle, MD, who spoke at the recent American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research. However, certain measures can be taken to lower false-positive and overdiagnosis rates, lessen costs, ameliorate patient suffering, and correctly identify screening cohorts, she asserted.
April 2013 Vol 4, No 2 | June 17, 2013
Since the publication of the positive results of the National Lung Screening Trial (NLST)—the first lung cancer screening trial to demonstrate a reduction in lung cancer mortality—in the New England Journal of Medicine in 2011, several uncertainties regarding implementation of widespread lung cancer screening have arisen.
February 2013 Vol 4, No 1 | April 2, 2013
The American Cancer Society reports that lung cancer is the leading cause of cancer death for both men and women and that more people die each year from lung cancer than from cancer of the colon, breast, and prostate combined.
February 2011 Vol 2, No 1 | September 7, 2011
Lung cancer is the most common type of cancer in the United States.
February 2011 Vol 2, No 1 | September 7, 2011
Maintenance therapy has begun to emerge as a treatment standard for patients with non–small cell lung cancer (NSCLC) whose disease has not progressed after 4 to 6 cycles of frontline chemotherapy.
February 2011 Vol 2, No 1 | September 7, 2011
Improving outcomes for patients with non–
small cell lung cancer (NSCLC) is particularly
relevant because NSCLC accounts for 85%
of all cases of lung cancer.
February 2011 Vol 2, No 1 | September 7, 2011
Significant advances in treating non–small cell
lung cancer (NSCLC) have been made over the
past 10 years; nevertheless, survival im provement
in this disease pales compared with many other
solid tumors. Because maintenance chemotherapy offers improved survival in NSCLC,
patients and doctors are justifiably excited.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512